Total Costs & Expenses

$229.60M

Quarterly · Period ending: Jun 30, 2026 · USD

MYGN Total Costs & Expenses

Latest reported$229.60Mperiod endingJun 30, 2026

MYGN Quarterly Total Costs & Expenses ($0.00 → $229.60M)

Quarterly Total Costs & Expenses

High-resolution chart · PNG

MYGN total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Total Costs & Expenses — Quarterly (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2026	229,600,000
Mar 31, 2026	231,100,000
Dec 31, 2025	215,500,000
Sep 30, 2025	229,000,000
Jun 30, 2025	542,300,000
Mar 31, 2025	224,900,000
Dec 31, 2024	249,600,000
Sep 30, 2024	233,300,000
Jun 30, 2024	248,000,000
Mar 31, 2024	230,100,000
Dec 31, 2023	228,000,000
Sep 30, 2023	252,000,000
Jun 30, 2023	297,200,000
Mar 31, 2023	233,400,000
Dec 31, 2022	230,000,000
Sep 30, 2022	201,400,000
Jun 30, 2022	197,100,000
Mar 31, 2022	190,500,000
Dec 31, 2021	203,900,000
Sep 30, 2021	247,200,000
Jun 30, 2021	210,200,000
Mar 31, 2021	219,800,000
Dec 31, 2020	0
Sep 30, 2020	184,800,000
Jun 30, 2020	161,500,000
Mar 31, 2020	297,700,000
Dec 31, 2019	203,900,000
Sep 30, 2019	207,200,000
Jun 30, 2019	221,000,000
Mar 31, 2019	210,700,000
Dec 31, 2018	210,700,000
Sep 30, 2018	201,100,000
Jun 30, 2018	185,200,000
Mar 31, 2018	169,300,000
Dec 31, 2017	181,600,000
Sep 30, 2017	94,800,000
Jun 30, 2017	183,500,000
Mar 31, 2017	189,200,000
Dec 31, 2016	179,500,000
Sep 30, 2016	171,800,000
Jun 30, 2016	150,800,000
Mar 31, 2016	147,900,000
Dec 31, 2015	148,100,000
Sep 30, 2015	140,200,000
Jun 30, 2015	153,686,000
Mar 31, 2015	144,300,000
Dec 31, 2014	148,100,000
Sep 30, 2014	142,900,000
Jun 30, 2014	135,512,000
Mar 31, 2014	127,637,000
Dec 31, 2013	121,061,000
Sep 30, 2013	119,563,000
Jun 30, 2013	108,199,000
Mar 31, 2013	98,554,000
Dec 31, 2012	93,554,000
Sep 30, 2012	84,855,000
Jun 30, 2012	85,679,000
Mar 31, 2012	83,681,000
Dec 31, 2011	77,346,000
Sep 30, 2011	68,980,000
Jun 30, 2011	65,635,000
Mar 31, 2011	60,550,000
Dec 31, 2010	61,854,000
Sep 30, 2010	56,267,000
Jun 30, 2010	56,313,000
Mar 31, 2010	57,605,000
Dec 31, 2009	58,246,000
Sep 30, 2009	55,410,000
Jun 30, 2009	7,941,000
Mar 31, 2009	51,271,000
Dec 31, 2008	50,635,000
Sep 30, 2008	60,338,000
Jun 30, 2008	100,642,000
Mar 31, 2008	69,581,000
Dec 31, 2007	65,478,000
Sep 30, 2007	59,848,000
Jun 30, 2007	57,744,000
Mar 31, 2007	50,062,000
Dec 31, 2006	25,766,000
Sep 30, 2006	48,543,000
Jun 30, 2006	46,006,000
Mar 31, 2006	41,763,000
Dec 31, 2005	36,930,000
Sep 30, 2005	35,167,000
Jun 30, 2005	34,837,000
Mar 31, 2005	30,671,000
Dec 31, 2004	30,315,000
Sep 30, 2004	27,327,000
Jun 30, 2004	25,994,000
Mar 31, 2004	24,920,000
Dec 31, 2003	24,529,000
Sep 30, 2003	23,840,000
Jun 30, 2003	23,378,000
Mar 31, 2003	22,199,000
Dec 31, 2002	24,508,000
Sep 30, 2002	21,583,000
Jun 30, 2002	21,580,092
Mar 31, 2002	17,500,468
Dec 31, 2001	17,258,195
Sep 30, 2001	16,157,000